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Relapsing fever Borrelia infections have attracted little
attention in recent years; however, where endemic, these
infections still result in considerable illness and death.
Despite the marked antimicrobial drug susceptibility of
these organisms, therapy is often delayed through lack of
clinical suspicion. With increasing travel, infections may be
imported, through exotic relapsing fever infection or
through resurgence of infected disease vectors. Although
louseborne relapsing fever is now geographically limited, it
was once of global importance. The possibility for reemer-
gence was recently highlighted by the probable reemer-
gence of louseborne relapsing fever in homeless persons
from France. Host limitations enforced through louseborne
transmission are less applicable for the tickborne forms of
relapsing fever. Although the latter have reduced potential
for epidemic spread, they have the ability to infect diverse
hosts, thus establishing reservoirs of infection and present-
ing greater challenges for their control. 
Since the 1980s, the number of Borrelia species associ-ated with relapsing fever has doubled. This situation is
in part due to improved diagnostics and molecular tech-
niques that have enabled sequenced-based characterization
of these spirochetes. Seventeen species are attributed to the
relapsing fever group of spirochetes; others have been
described but await further characterization and isolation
before species can be designated. Infection is vectorborne,
primarily by Ornithodoros ticks, which led to the descrip-
tive name of tickborne relapsing fever. However, 1 form of
the disease developed epidemic potential by adapting to
louse transmission and thus became known as louseborne
relapsing fever.
Clinically, these spirochetes all produce an undulating
febrile disease in humans, with signs and symptoms often
indistinguishable from those of malaria. Diagnosis in most
disease-endemic areas relies on demonstrating the spiro-
chete in Giemsa-stained blood films; however, more dis-
criminating methods are available that can be used in suit-
ably equipped facilities.
Whether we are likely to see the reemergence of this
disease is difficult to predict because we do not understand
relapsing fever borreliae and their complex host interac-
tions. Indeed, to use the words of Bryceson et al., “Little is
understood of where it lurks between epidemics and of
how it suddenly springs up after silent intervals of several
years” (1). The same authors describe the louseborne dis-
ease as the “most epidemic of the epidemic diseases.”
Certainly, increasing population movements and travel to
disease-endemic areas are likely to introduce relapsing
fever to areas where it is not been common. Here, the dan-
ger lies in not considering this diagnosis or mislabeling the
disease as Lyme borreliosis because of the likely cross-
reactive serologic results. Although the louseborne epi-
demic form of the disease was once distributed globally, it
is now localized to a few countries. The recent documen-
tation of probable cases in homeless populations in France
raises the possibility of reintroduction of this disease in
countries where it was believed to have been eliminated.
Discovery of the Disease
Compatible clinical disease descriptions have been
documented since the time of Hippocrates; however, the
term relapsing fever was first used by David Craigie to
describe an outbreak of the disease in Edinburgh in 1843
(1). The spirochetal cause for louseborne relapsing fever
was first demonstrated by Otto Obermeier during an out-
break in Berlin (1867–1868). His inability to reproduce the
disease in animal models (and indeed in himself) delayed
the publication of these findings until 1873 (1). The
causative agent of the African tick variety of relapsing
fever was discovered by Ross and Milne in 1904 (2). This
finding was also made independently by Dutton and Todd,
who demonstrated transmission by using infected
Ornithodoros moubata ticks and a monkey model (3). The
publication of their findings in 1905 resulted from the fact
Possibilities for Relapsing 
Fever Reemergence
Sally J. Cutler*
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 3, March 2006 369
*Veterinary Laboratories Agency, Surrey, United Kingdom
that Dutton became infected with this spirochete. The role
of the human body louse in the transmission of relapsing
fever was reported by MacKie in 1907 (1).
Historical Epidemics and Endemic Disease Foci
During the first half of the 20th century, relapsing fever
was a disease of major worldwide importance; it caused
epidemics affecting ≈50 million and was associated with
death rates of 10% to 40% (1). During the 1930s, approx-
imately one third of the population in Africa was devastat-
ed by an epidemic attributed to relapsing fever. Since
1967, the epidemic form of louseborne relapsing fever has
been largely confined to areas of extreme poverty in East
Africa (4) and the Peruvian Andes; most cases occur in
Ethiopia. A recent outbreak in neighboring Sudan is esti-
mated to have affected 20,000 members of the Dinka tribe
in 1998 and 1999; the death rate was 10%–14%. Despite
the reappearance elsewhere in the world of other louse-
borne diseases, such as epidemic typhus in Burundi and
trench fever in vagrant populations, little evidence of
reemergence of louseborne relapsing fever exists.
Furthermore, molecular analysis of lice collected from
around the world, including France, Peru, Russia, and the
African countries of Burundi, Congo and Zimbabwe, did
not produce evidence of infection with the louseborne
relapsing fever agent (5). 
Tickborne relapsing fevers may be endemic or spo-
radic. They still cause major health problems in Africa; in
areas such as central Tanzania, this disease is a substantial
cause of child deaths (4,6). Although present in some
European countries, Central Asia, the Middle East, and the
Americas, tickborne relapsing fever tends to be rarer
(7–10). It is often associated with camping out in rural
locations in close proximity to animal reservoirs of the
spirochete and their associated Ornithodoros tick vectors
(Figure 1) (7–9).
Relapsing Fever Today
This disease still has persistent foci of infection, where
control can be a major healthcare problem. Relapsing fever
can be acquired by travelers and brought back to regions
where the disease is not epidemic (10,11) after eco-chal-
lenges or in association with military training or activities
such as camping or caving, provided susceptible hosts and
natural disease ecologic cycles coincide (8,9). Although
many would argue that this limited disease impact is not a
threat to public health, the lack of consideration of relaps-
ing fever as a potential cause of clinical findings is a cause
for concern. 
Tickborne Relapsing Fevers
Borrelia duttonii, the cause of tickborne relapsing
fever, is endemic to several countries in East Africa, such
as Tanzania. No accurate data on the number of cases in
Tanzania exist because this infection is not reportable in
the Ministry of Health’s Health Management Information
System. Estimates of the incidence are likely to be grossly
underestimated because many cases are diagnosed as
malarial treatment failures.  Localized studies have shown
that the annual incidence is 384/1,000 in children <1 year
of age and 163/1,000 in children <5 years of age (4), while
other researchers have reported an incidence of 59/1,000
(12). B. duttonii infection primarily occurs in children and
pregnant women, and it is associated with fetal loss and
neonatal deaths. A perinatal death ratio of 436/1,000 has
been reported from disease-endemic regions of Tanzania
(4).
The vector is the soft tick, genus Ornithodoros; the
species complex Ornithodoros moubata is prevalent in
sub-Saharan Africa. These ticks live in traditional housing
and mainly feed nocturnally (Figures 2 and 3). The disease
is transmitted either by saliva during tick feeding or in
coxal fluid excreted during feeding. The tick feeds for a
short time only (usually less than half an hour), then
returns to the earth floor or walls of the house. Humans are
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Figure 2. Traditional Tembe dwelling in Tanzania.
Figure 1. Ornithodoros moubata ticks that frequent traditional
homes. 
believed to be the only natural reservoir for B. duttonii,
unlike the situation for B. crocidurae in West Africa, where
rodents are reservoirs. (Up to 18% of rodents from Senegal
are infected with this spirochete [13]). Human infection
with B. crocidurae appears to be more prevalent than pre-
viously described, however (14). This increase could be
attributed to improved diagnostic capabilities and sample
processing (15), but it is largely due to molecular tech-
niques that can facilitate not only detection but also subse-
quent identification through sequencing the target gene
(16,17).
Reports of tickborne relapsing fever elsewhere appear
to be more sporadic or involve limited clusters of infec-
tion, which typically are associated with events that bring
susceptible human hosts into close proximity with the tick
vectors and their usual wildlife reservoirs (8,9). The
species most frequently incriminated in such cases include
B. turicatae and B. hermsii. Isolated reports of B. persica
infection transmitted by its O. tholozani vector have also
appeared in the Middle East (9), and B. hispanica trans-
mission has been reported in Spain and North Africa (10).
Louseborne Relapsing Fevers
Many now believe that louseborne relapsing fever can
be assigned to the history books; however, considerable
disease-endemic foci of infection remain in areas of
Ethiopia, which spill into neighboring countries such as
Sudan (18). This global reduction of louseborne relapsing
fever has largely resulted from the demise of the human
clothing louse through improved human living conditions.
A cause for concern is the increasing preference for wash-
ing clothes at low temperatures, which could permit louse
survival. Ideally, clothes should be washed in water >60°C
to kill lice. These lice are unable to survive away from
their human hosts for more than a matter of hours and con-
sequently tend to persist in areas of extreme poverty or in
association with major population upheavals and turmoil,
such as wars or environmental disasters. The increase of
clothing lice among less privileged persons in industrial-
ized countries is a growing concern. Blood samples col-
lected from homeless persons in France from 2000 to 2003
showed serologic reactivity against B. recurrentis, which
suggests a small disease outbreak and serves as a reminder
against complacency against controlling or eliminating
this disease (19).
Potential for Introduction or Reintroduction 
into Industrialized Countries
The ability of these spirochetes to remain associated
with their arthropod vectors throughout the lifespan of the
vector is well established (20). However, most show limit-
ed capacity for transovarial transmission (21) since these
spirochetes are typically transmitted through soft ticks or
clothing lice, both of which only feed for a short duration
(<30 minutes) before sequestering in cracks and crevices
or seams of clothing.
Neither soft ticks nor lice can “travel” from their partic-
ular ecologic niches. However, finding Borrelia spp. that
greatly resemble relapsing fever borreliae with natural
transmission through hard tick (ixodid) vectors means that
these ticks may play a role in transmission. Ixodid ticks
have been found in association with seafaring birds and
songbirds, which raises the possibility of migration-associ-
ated transmission. Furthermore, the finding of novel
Borrelia spp. in Africa that strongly resemble New World
relapsing fever species suggests greater globalization of
these spirochetes (22–24). As yet, the possible clinical
importance of these spirochetes, for which the name
“Candidatus Borrelia mvumii” has been proposed,
remains unresolved (16,22,23). Studies are particularly
hampered by the current lack of cultivatable strains.
Studies of rodents in California have shown a new
potential borrelial species, tentatively named “Borrelia
davisii,” which appears distinct from both the Lyme-asso-
ciated and relapsing fever groups of spirochetes. Despite
the finding of this spirochete in blood samples collected
from rodents, Ixodes scapularis ticks collected from the
same geographic region were uniformly negative, which
indicates that an alternative vector may exist for this spiro-
chete. The clinical importance, if any, remains to be ascer-
tained.
Lice are restrained by their exquisite host specificities.
Human clothing lice have been adapted to feeding on a
rabbit host (20); however, they still show strong preference
for their human hosts. Whether other species of lice, or
indeed other arthropod vectors, could transmit louseborne
spirochetes is an open question. More recently, excretion
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Figure 3. Ornithodoros moubata ticks feeding on sleeping children.
of B. recurrentis in louse feces has been demonstrated
(20). Louse feces, in turn, could become aerosolized
through desiccation and dispersal, potentially increasing
possibilities for spread of this infection; however, this
route of transmission currently is anecdotal.
The possibility that the agents of louseborne epidemic
relapsing fever (B. recurrentis) and of East African tick-
borne relapsing fever (B. duttonii) may indeed be the same,
or highly related clones of a common ancestor, has been
raised (24). Phylogenetic comparisons have demonstrated
the homology between these spirochetes and resemblance
with the West African B. crocidurae species (16,17,24).
More recently, analysis of an intragenic spacer typing
method for these spirochetes, although showing clear dif-
ferences between B. crocidurae, was unable to discrimi-
nate between B. recurrentis and B. duttonii (24). If indeed
these strains are homogeneous, the potential transmission
of the louseborne B. recurrentis by tick vectors must be
considered.
Travel patterns have changed in recent years, particu-
larly in more affluent nations; remote rural areas are par-
ticularly popular. Thus, imported cases associated with
tourists returning to their home countries are likely (10).
Vacation-associated infection with B. hermsii and B. turi-
catae has been reported from the Americas (8), while trav-
el-associated cases of B. crocidurae and B. hispanica
infection have been reported in Europe (10,15). Marked
differences in the incidence of disease have been noted
between civilian populations, who are becoming increas-
ingly urbanized, and military populations, who have
greater potential contact with rural environments during
training exercises (9). Subsequent febrile illness is likely to
be diagnosed as malaria; however, microscopic examina-
tion of Giemsa-stained blood films should show the spiro-
chetal cause of such cases. Of concern is the ability of
spirochetes to persist within the blood of patients long after
fever resolves (10). Several mechanisms facilitate this per-
sistence, including antigenic variation, binding of factor H,
and rosetting of erythrocytes (25–27). Furthermore,
increased movements of animals, their produce, and even
fomites make alternative vehicles for transportation of
these diseases likely, either through undiagnosed infection
or transport of the vectors themselves. This was likely the
route for introduction of West Nile virus into the United
States.
Reservoirs of Infection and Vector Control
Natural Reservoirs
The role of wildlife as natural reservoirs for Borrelia
spp. (particularly rodents, warthogs, or other mammalian
hosts) is well established; most relapsing fevers rarely
affect humans (13,28). In contrast, B. duttonii and B.
recurrentis have no identified natural hosts other than
humans. For these 2 spirochetes, whether the vector is also
the reservoir (with the human’s role being amplification of
infected vectors) or if humans can be considered as the
reservoir for infection is debatable. Recent work by
Kisinza et al. in the Dodoma region of Tanzania found 5%
of febrile children had positive blood slides for Borrelia
spp. (22). Others studying nonfebrile persons have report-
ed that 3% of them are spirochetemic by blood film exam-
ination. Furthermore, our own population studies on
incidence in randomly chosen villagers in 4 Tanzanian vil-
lages showed that 11% were positive for borrelial DNA by
using polymerase chain reaction. Whether this level of
infection is sufficient to sustain the disease is not known.
Livestock
The role of livestock as hosts is not well established;
however, a recent case report described equine abortion
associated with a spirochete resembling B. parkeri and B.
turicatae (29). This case also indicates that infection may
be associated with livestock transportation. Whether other
livestock or companion animals are susceptible to infec-
tion remains to be established. 
Vectors
Many diseases now considered to be emerging or
reemerging threats are vectorborne. Factors contributing to
this phenomenon include changes to natural habitats, cli-
matic change, and different levels of vector control strate-
gies.
The stringent host specificity of the louse vector is the
probable reason for the current demise of louseborne
relapsing fever. In contrast, tick vectors are less host-spe-
cific; thus, spirochetes can be transmitted to more diverse
hosts. Short-term vector control methods can be instigated,
such as through use of acaricides. Although these methods
have met with some success, we also need more afford-
able, yet sustainable, means of intervention that are likely
to break the natural transmission cycles or reduce contact
between reservoir, vector, and susceptible hosts (6).
Improvements in housing design or institution of physical
barriers such as bed nets could reduce vectors’ access to
susceptible hosts. Although these measures could reduce
disease under certain circumstances, they offer little pro-
tection for populations at high risk, such as the homeless in
industrialized countries.
Host-Pathogen Relationships
Spirochetes must be maintained within the circulatory
system of the host, thus enabling transmission to uninfect-
ed co-feeding or subsequently feeding arthropod vectors.
Host blood persistence appears to be the result of many
interactions between the host and spirochete. The ability of
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these spirochetes to undergo antigenic variation is well
documented (25). Briefly, successive waves of spiro-
chetemia characteristically seen in relapsing fever are
associated with different antigenic variants, which result
from rearrangement of silent variable membrane protein
genes into an expression locus. This repertoire may be fur-
ther extended through the multiplicity of mosaiclike vari-
able membrane protein genes and pseudogenes possessed
by some members of this group. These genes may have a
role in extending antigenic diversity akin to the combina-
tional gene conversion described in Anaplasma marginale
(30).
This description does not address the question of
whether spirochetes associated with clinical cases differ
from those that do not appear to cause overt clinical signs.
Immunity is a factor, highlighted by the high prevalence of
disease in young children and pregnant women. However,
for humans to serve as reservoirs for this disease, the spiro-
chete must persist in sufficient numbers in a site where
they will be acquired by new arthropod vectors. An
intriguing hypothesis is that particular antigenic variants of
the spirochete may be associated with life in an arthropod
vector (usually ticks, except for the related spirochete, B.
recurrentis), while others are suited to persistence in their
human host (disease reservoir); additional types are asso-
ciated with patients with overt clinical signs mediated
through a multiplicity of host-microbe interactions.
Persistence may be further facilitated through the neu-
rotrophic tendency of these spirochetes. This hypothesis is
further strengthened by observed pathologic differences
associated with isogenic variants of the same isolate of B.
turicatae investigated in vivo (31).
Clinical manifestations and patient management fall
largely outside the scope of this review. However, clinical
findings are reported elsewhere (1), in particular, details of
management of neurologic, respiratory, and cardiac com-
plications of these diseases. 
Both innate and acquired immune responses are needed
to control infection. To overcome innate immune mecha-
nisms, these spirochetes bind the complement inhibitor
factor H to their surface, thus avoiding deposition of the
membrane attack complex and subsequent lysis (26; Meri
et al., unpub. data). Clearance of spirochetes is primarily
mediated through production of specific bactericidal
immunoglobulin M antibodies (32); complement is not
required (33). This specific immunoglobulin is primarily
directed against the outer membrane lipoproteins of these
spirochetes. T cells do not appear to have a major role in
the resolution of spirochetemia (32).
Another mechanism that may enhance persistence of
these spirochetes within the bloodstream is the ability of
some relapsing fever spirochetes to become coated with or
to rosette blood erythrocytes. This process enables pro-
longed persistence through a masking or steric hindrance
effect, which prevents interaction with the host immune
cells (27,34). This ability to bind erythrocytes might be
associated with pathologic observations, including vascu-
lar tissue damage, hemorrhages, and inflammation (27);
however, this hypothesis would not explain similar patho-
logic observations in nonrosetting phylogenetically related
borreliae.
Future Prospects
Traditionally, diagnosis is based on demonstration of
spirochetes in blood films taken during the acute febrile
period. More recently, an enzyme-linked immunosorbent
assay that used the GlpQ gene product was demonstrated
to be a useful diagnostic aid (35). Furthermore, this antigen
is specific for the relapsing fever group borreliae, thus dis-
tinguishing these from cases of Lyme borreliosis (35).
Characterization of relapsing fever Borrelia spp. can
now be facilitated through molecular approaches that
allow more accurate investigation of which species are
prevalent in different epidemiologic foci. Previously, such
characterization relied on identification of disease vectors
and compatibility with established geographic patterns.
Furthermore, these techniques will enable characterization
of newly discovered spirochetes (36) and identification of
their reservoirs of infection. For example, spirochetes that
were described in the guts of termites have now been allo-
cated to a separate genus (37). Additional spirochetes have
been identified in soil; however, their taxonomic status and
clinical importance remain to be established (38). Other
spirochetes have been discovered in various tick species,
some showing rapid in vitro growth (39) and others pro-
ducing no cultivable isolates to date (22).
Genome sequencing is under way for several relapsing
fever spirochetes. This information will enable a thorough
comparative analysis of these spirochetes and likely yield
insights into vector competence and pathogenicity.
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